Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 158

1.

Cancer stem cells.

Morrison SJ.

Clin Adv Hematol Oncol. 2005 Mar;3(3):171-2. No abstract available.

PMID:
16166988
2.

Stem cells, aging, and cancer: inevitabilities and outcomes.

Bell DR, Van Zant G.

Oncogene. 2004 Sep 20;23(43):7290-6. Review.

PMID:
15378089
3.

Tumor growth need not be driven by rare cancer stem cells.

Kelly PN, Dakic A, Adams JM, Nutt SL, Strasser A.

Science. 2007 Jul 20;317(5836):337.

4.

Concepts of human leukemic development.

Warner JK, Wang JC, Hope KJ, Jin L, Dick JE.

Oncogene. 2004 Sep 20;23(43):7164-77. Review.

PMID:
15378077
5.

Mechanisms controlling pathogenesis and survival of leukemic stem cells.

Jordan CT, Guzman ML.

Oncogene. 2004 Sep 20;23(43):7178-87. Review.

PMID:
15378078
6.

Neoplastic stem cells: a novel therapeutic target in clinical oncology.

Schulenburg A, Ulrich-Pur H, Thurnher D, Erovic B, Florian S, Sperr WR, Kalhs P, Marian B, Wrba F, Zielinski CC, Valent P.

Cancer. 2006 Nov 15;107(10):2512-20. Review.

7.

Chronic granulocytic leukemia: the heterogeneity of stem cell differentiation within a single disease entity.

Canellos GP, Griffin JD.

Semin Oncol. 1985 Sep;12(3):281-8. Review. No abstract available.

PMID:
3901265
8.

Acute biphenotypic leukaemia.

Chim CS, Ma SK.

Haematologica. 2002 Jan;87(1):EIM03. No abstract available.

PMID:
11801484
9.

Cancer stem cells: a review.

Spillane JB, Henderson MA.

ANZ J Surg. 2007 Jun;77(6):464-8. Review.

PMID:
17501888
10.

Acute leukemia with extramedullary presentation and mixed myeloid and lymphoid expression.

Bayle C, Romdhane NB, Bastard C, Vannier JP, Hayat M, Lemerle J, Bernard A.

Pediatr Hematol Oncol. 1986;3(3):293-6. No abstract available.

PMID:
3153242
11.

Expression of the hemoglobin scavenger receptor (CD163/HbSR) as immunophenotypic marker of monocytic lineage in acute myeloid leukemia.

Walter RB, Bächli EB, Schaer DJ, Rüegg R, Schoedon G.

Blood. 2003 May 1;101(9):3755-6. No abstract available.

12.

Overt expression of H-2 serotypes on EC cells is not necessary for host rejection.

Maher LJ 3rd, Dove WF.

Immunogenetics. 1984;19(4):343-7. No abstract available.

PMID:
6715024
13.

The role of cancer stem cells in neoplasia of the lung: past, present and future.

Yagui-Beltrán A, He B, Jablons DM.

Clin Transl Oncol. 2008 Nov;10(11):719-25. Review.

PMID:
19015068
14.

Deficient expression of NCR in NK cells from acute myeloid leukemia: Evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction.

Fauriat C, Just-Landi S, Mallet F, Arnoulet C, Sainty D, Olive D, Costello RT.

Blood. 2007 Jan 1;109(1):323-30. Epub 2006 Aug 29.

15.

Cancer research. Mutant stem cells may seed cancer.

Marx J.

Science. 2003 Sep 5;301(5638):1308-10. No abstract available.

PMID:
12958339
16.

Stem cells: the real culprits in cancer?

Clarke MF, Becker MW.

Sci Am. 2006 Jul;295(1):52-9. No abstract available.

PMID:
16830680
17.

Comment on "Tumor growth need not be driven by rare cancer stem cells".

Kennedy JA, Barabé F, Poeppl AG, Wang JC, Dick JE.

Science. 2007 Dec 14;318(5857):1722; author reply 1722.

18.

Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9.

Krivtsov AV, Twomey D, Feng Z, Stubbs MC, Wang Y, Faber J, Levine JE, Wang J, Hahn WC, Gilliland DG, Golub TR, Armstrong SA.

Nature. 2006 Aug 17;442(7104):818-22. Epub 2006 Jul 16.

PMID:
16862118
19.

On the genesis and regulation of cellular heterogeneity in malignant tumors.

Poste G, Greig R.

Invasion Metastasis. 1982;2(3):137-76. Review.

PMID:
6765249
20.

Simultaneous occurrence of chronic granulocytic leukemia and chronic lymphoid leukemia.

Leoni F, Ferrini PR, Castoldi GL, Pata M, Del Prete GF, Tomasi P.

Haematologica. 1987 May-Jun;72(3):253-6. No abstract available.

PMID:
3114094

Supplemental Content

Support Center